четверг, 7 января 2016 г.

EQIS Capital Management Boosts Stake in Sinovac Biotech Ltd.

EQIS Capital Management Boosts Stake in Sinovac Biotech Ltd.


EQIS Capital Management boosted its position in Sinovac Biotech Ltd. by 6,472.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission . The firm owned 240,674 shares of the biopharmaceutical company's stock after buying an additional 237,012 shares during the period.



from Biotech News